Ergoteles’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Ergoteles’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-146,759	Closed	-$6.82M	–	980
2023 Q2	$6.82M	Buy	146,759 +119,617	+441%	+$4.13M	0.33%	71
2023 Q1	$778K	Buy	+27,142	New	+$804K	0.03%	588
2021 Q4	–	Sell	-40,800	Closed	-$1.34M	–	1704
2021 Q3	$1.34M	Buy	+40,800	New	+$1.39M	0.05%	325

Ergoteles's DICE Position: Q3 2023 in Review

Ergoteles sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 146,759 shares — an estimated $6.82M sold.

Ergoteles first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $6.82M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Ergoteles reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 146,759 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.82M.
Ergoteles first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Ergoteles's DICE Therapeutics, Inc. Common Stock position peaked at $6.82M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.